Achieving Localised Delivery With Magnetic Vectoring - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Achieving Localised Delivery With Magnetic Vectoring
Charles E. Seeney tells us about the possibilities of nanotechnology and magnetism, and how a novel approach could improve localised drug delivery.


Pharmaceutical Technology Europe


References

1. Magnetism in Medicine: A Handbook, Wilfried Andrä and Hannes Nowak, Eds. (Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany, 2nd ed., 2007).

2. M.N. Faddis et al., Circulation 106(23), 2980–2985 (2002).

3. M. Baumann et al., Rofo 178(9), 911–917 (2006).

4. J. Klostergaard et al, Future Medicines: Nanomedicine (In press, 2012).

5. R. Bawa, Nanotechnology Law and Business 5, 135–155 (2008).

6. S. Laurent S and M. Mahmoudi, Int. J. Mol. Epidemiol. Genet. 2(4), 367–390 (2011).

7. J. Klostergaard et al., AIP Conference Proceedings (Germany, 2010) pp. 382–387

8. J. Klostergaard et al., J. Magnetism Magnetic Materials 311(1) (2007).

9. C. Plank et al., Expert Opin. Biol. Ther. 3(5), 745–758 (2003).

10. M. Johannsen et al., Int. J. Hyperthermia 21(7), 637–747 (2005).

11. C.E. Seeney et al., Biomaterials, 26(14), (2005).

12. P.Y. Chen et al., Neuro Oncol. 12(10), 1050–60 (2010).

13. M.Y. Hua et al., Biomaterials 32(2), 516–27 (2011).

14. G. Lian et al., Microsc Microanal 10, Suppl. 2 (2004).

15. M. Ma, A: Physicochem. Eng. Aspects 212, 219–226 (2003).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
30%
Attracting a skilled workforce
27%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
30%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans
Source: Pharmaceutical Technology Europe,
Click here